316 related articles for article (PubMed ID: 21219598)
1. Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: design of a multicenter randomized clinical trial.
Wevers MR; Ausems MG; Verhoef S; Bleiker EM; Hahn DE; Hogervorst FB; van der Luijt RB; Valdimarsdottir HB; van Hillegersberg R; Rutgers EJ; Aaronson NK
BMC Cancer; 2011 Jan; 11():6. PubMed ID: 21219598
[TBL] [Abstract][Full Text] [Related]
2. Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trial.
Wevers MR; Aaronson NK; Verhoef S; Bleiker EM; Hahn DE; Kuenen MA; van der Sanden-Melis J; Brouwer T; Hogervorst FB; van der Luijt RB; Valdimarsdottir HB; van Dalen T; Theunissen EB; van Ooijen B; de Roos MA; Borgstein PJ; Vrouenraets BC; Vriens E; Bouma WH; Rijna H; Vente JP; Witkamp AJ; Rutgers EJ; Ausems MG
Br J Cancer; 2014 Feb; 110(4):1081-7. PubMed ID: 24423928
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients.
Schwartz MD; Peshkin BN; Isaacs C; Willey S; Valdimarsdottir HB; Nusbaum R; Hooker G; O'Neill S; Jandorf L; Kelly SP; Heinzmann J; Zidell A; Khoury K
Breast Cancer Res Treat; 2018 Aug; 170(3):517-524. PubMed ID: 29611029
[TBL] [Abstract][Full Text] [Related]
4. Does rapid genetic counseling and testing in newly diagnosed breast cancer patients cause additional psychosocial distress? results from a randomized clinical trial.
Wevers MR; Ausems MG; Verhoef S; Bleiker EM; Hahn DE; Brouwer T; Hogervorst FB; van der Luijt RB; van Dalen T; Theunissen EB; van Ooijen B; de Roos MA; Borgstein PJ; Vrouenraets BC; Vriens E; Bouma WH; Rijna H; Vente JP; Kieffer JM; Valdimarsdottir HB; Rutgers EJ; Witkamp AJ; Aaronson NK
Genet Med; 2016 Feb; 18(2):137-44. PubMed ID: 25905441
[TBL] [Abstract][Full Text] [Related]
5. How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.
Watts KJ; Meiser B; Mitchell G; Kirk J; Saunders C; Peate M; Duffy J; Kelly PJ; Gleeson M; Barlow-Stewart K; Rahman B; Friedlander M; Tucker K;
BMC Cancer; 2012 Jul; 12():320. PubMed ID: 22838957
[TBL] [Abstract][Full Text] [Related]
6. Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study.
Wevers MR; Schmidt MK; Engelhardt EG; Verhoef S; Hooning MJ; Kriege M; Seynaeve C; Collée M; van Asperen CJ; Tollenaar RA; Koppert LB; Witkamp AJ; Rutgers EJ; Aaronson NK; Rookus MA; Ausems MG
Fam Cancer; 2015 Sep; 14(3):355-63. PubMed ID: 25700605
[TBL] [Abstract][Full Text] [Related]
7. What made her give up her breasts: a qualitative study on decisional considerations for contralateral prophylactic mastectomy among breast cancer survivors undergoing BRCA1/2 genetic testing.
Kwong A; Chu AT
Asian Pac J Cancer Prev; 2012; 13(5):2241-7. PubMed ID: 22901201
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer genetic counseling after diagnosis but before treatment: a pilot study on treatment consequences and psychological impact.
Wevers MR; Hahn DE; Verhoef S; Bolhaar MD; Ausems MG; Aaronson NK; Bleiker EM
Patient Educ Couns; 2012 Oct; 89(1):89-95. PubMed ID: 22543000
[TBL] [Abstract][Full Text] [Related]
9. DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct.
Sie AS; Spruijt L; van Zelst-Stams WA; Mensenkamp AR; Ligtenberg MJ; Brunner HG; Prins JB; Hoogerbrugge N
BMC Womens Health; 2012 May; 12():12. PubMed ID: 22569005
[TBL] [Abstract][Full Text] [Related]
10. Psychosocial impact of proactive rapid genetic counseling following breast cancer diagnosis.
Kritzik R; Usoro E; Peshkin BN; Isaacs C; Valdimarsdottir HB; Willey S; O'Neill S; DeMarco T; Nusbaum R; Jandorf L; Kelleher S; Schwartz MD
Psychooncology; 2022 May; 31(5):788-797. PubMed ID: 34921700
[TBL] [Abstract][Full Text] [Related]
11. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
[TBL] [Abstract][Full Text] [Related]
12. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
[TBL] [Abstract][Full Text] [Related]
13. Rapid genetic counseling and testing in newly diagnosed breast cancer: Patients' and health professionals' attitudes, experiences, and evaluation of effects on treatment decision making.
Wevers MR; Aaronson NK; Bleiker EMA; Hahn DEE; Brouwer T; van Dalen T; Theunissen EB; van Ooijen B; de Roos MA; Borgstein PJ; Vrouenraets BC; Vriens E; Bouma WH; Rijna H; Vente JP; Kuenen MA; van der Sanden-Melis J; Witkamp AJ; Rutgers EJT; Verhoef S; Ausems MGEM
J Surg Oncol; 2017 Dec; 116(8):1029-1039. PubMed ID: 28703900
[TBL] [Abstract][Full Text] [Related]
14. Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling.
Tong A; Kelly S; Nusbaum R; Graves K; Peshkin BN; Valdimarsdottir HB; Wood M; McKinnon W; Garber J; McCormick SR; Jandorf L; Schwartz MD
Psychooncology; 2015 Jan; 24(1):33-9. PubMed ID: 24839250
[TBL] [Abstract][Full Text] [Related]
15. Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.
Schwartz MD; Lerman C; Brogan B; Peshkin BN; Halbert CH; DeMarco T; Lawrence W; Main D; Finch C; Magnant C; Pennanen M; Tsangaris T; Willey S; Isaacs C
J Clin Oncol; 2004 May; 22(10):1823-9. PubMed ID: 15067026
[TBL] [Abstract][Full Text] [Related]
16. Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.
Culver JO; Brinkerhoff CD; Clague J; Yang K; Singh KE; Sand SR; Weitzel JN
Clin Genet; 2013 Nov; 84(5):464-72. PubMed ID: 23323793
[TBL] [Abstract][Full Text] [Related]
17. Effect of genetic counseling and testing for BRCA1 and BRCA2 mutations in African American women: a randomized trial.
Halbert CH; Kessler L; Troxel AB; Stopfer JE; Domchek S
Public Health Genomics; 2010; 13(7-8):440-8. PubMed ID: 20234119
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial.
Kautz-Freimuth S; Redaèlli M; Isselhard A; Shukri A; Vodermaier A; Rhiem K; Schmutzler R; Stock S
Trials; 2022 Feb; 23(1):157. PubMed ID: 35172875
[TBL] [Abstract][Full Text] [Related]
19. Risk-reduction surgery decisions in high-risk women seen for genetic counseling.
Ray JA; Loescher LJ; Brewer M
J Genet Couns; 2005 Dec; 14(6):473-84. PubMed ID: 16388328
[TBL] [Abstract][Full Text] [Related]
20. A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive Italian women.
Cortesi L; Razzaboni E; Toss A; De Matteis E; Marchi I; Medici V; Tazzioli G; Andreotti A; De Santis G; Pignatti M; Federico M
Ann Oncol; 2014 Jan; 25(1):57-63. PubMed ID: 24276029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]